HUB Organoids® derived from patients with chronic hepatitis B show the first molecular signs of liver cancer.

The molecular events that drive liver cell transformation following Hepatitis B virus (HBV) infection have remained largely unclear, due to the absence of a relevant primary model system.


Have any questions?

contact us